top of page

Cardiac Complications After SARS-CoV-2 Infection and mRNA COVID-19 Vaccination

PCORnet, United States, January 2021–January 2022

On April 1, 2022, this report was posted online as an MMWR Early Release.

Jason P. Block, MD1; Tegan K. Boehmer, PhD2; Christopher B. Forrest, MD, PhD3; Thomas W. Carton, PhD4; Grace M. Lee, MD5; Umed A. Ajani, MBBS2; Dimitri A. Christakis, MD6; Lindsay G. Cowell, PhD7; Christine Draper1; Nidhi Ghildayal, PhD1; Aaron M. Harris, MD2; Michael D. Kappelman, MD8; Jean Y. Ko, PhD2; Kenneth H. Mayer, MD9; Kshema Nagavedu, MPH1; Matthew E. Oster, MD2,10; Anuradha Paranjape, MD11; Jon Puro, MPA12; Matthew D. Ritchey2; David K. Shay, MD2; Deepika Thacker, MD13; Adi V. Gundlapalli, MD, PhD2

Summary What is already known about this topic?

Studies have found an increased risk for cardiac complications after SARS-CoV-2 infection and mRNA COVID-19 vaccination, but few have compared these risks.

What is added by this report? Data from 40 health care systems participating in a large network found that the risk for cardiac complications was significantly higher after SARS-CoV-2 infection than after mRNA COVID-19 vaccination for both males and females in all age groups.

What are the implications for public health practice? These findings support continued use of recommended mRNA COVID-19 vaccines among all eligible persons aged ≥5 years.

12 views0 comments

Recent Posts

See All

This article was published by the New York Post on February 27,2023. Author is Marty Makary MD, MPH a professor at the Johns Hopkins University School of Medicine and author of “The Price We Pay.” I

NAC is a natural antioxidant produced by the body. It is used to synthesize Glutathione (the most potent antioxidant in the body) within the blood. NAC is the precursor for Glutathione. This means tha

bottom of page